Results 221 to 230 of about 1,902,839 (316)
Impact of gestational weight gain on perineal injury in overweight and obese primiparous women. [PDF]
Gilboa I +6 more
europepmc +1 more source
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad +17 more
wiley +1 more source
Robust performance optimization of UAV dynamic systems using MPC-PID hybrid control. [PDF]
Zhou W, Zhou L, Yuan T, Chen R, Liu D.
europepmc +1 more source
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
A selection index with minimal genetic relatedness for multi-trait data via binary quadratic programming. [PDF]
Montesinos-López OA +3 more
europepmc +1 more source
A Study on the Taxation of Capital Gain from the Disposition of Treasury Stocks
Lee Ho
openalex +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Contributions of Sound Localization Cues to Azimuth Tuning in the Auditory Midbrain. [PDF]
Garretson E, Mencsik J, Day ML.
europepmc +1 more source
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard +12 more
wiley +1 more source

